Mirtazapin Hexal (Mirtazapine)

Mirtazapine blocks presynaptic α2‑adrenergic receptors, increasing norepinephrine release, and antagonizes postsynaptic 5‑HT2 and 5‑HT3 receptors. This dual action enhances overall serotonergic and noradrenergic neurotransmission, contributing to mood improvement.

The appropriate dose of Mirtazapin Hexal is determined individually by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are made according to clinical guidelines and patient needs.

Safety data for mirtazapine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mirtazapin Hexal (mirtazapine) belongs to the NaSSA class, offering a distinct receptor profile compared with SSRIs or SNRIs. It often provides stronger sedative and appetite‑stimulating effects, which can be advantageous for patients with insomnia or weight loss, but may be less suitable for those concerned about weight gain.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product integrity.

Mirtazapin Hexal is taken orally, usually once daily in the evening to take advantage of its sedative effect. Tablets should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe neutropenia, hyponatremia, and rare skin reactions such as Stevens‑Johnson syndrome. Early in treatment, patients should be monitored for worsening depression or emergent suicidal thoughts, especially in younger adults.

Mirtazapin Hexal should be avoided in patients with known hypersensitivity to mirtazapine or any excipients, those currently taking monoamine oxidase inhibitors, and individuals with severe hepatic impairment unless dose adjustments are made under specialist supervision.